New hope for kids with tough cancers: experimental drug LAM561 enters testing
Disease control
Recruiting now
This study tests an experimental drug called LAM561 in children under 18 with advanced brain tumors (like high-grade glioma) or other solid cancers that have not responded to standard treatments. The goal is to find a safe dose and check for side effects. Up to 28 children will t…
Phase: PHASE1, PHASE2 • Sponsor: Laminar Pharmaceuticals • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC